Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
Recruiting · NCT05708859 · Registry updated 2024-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT | Arterial Occlusive Diseases, Nutritional and Metabolic Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus, vascular disorder | Recruiting | Phase 4 | 2024-10-15 | NCT05708859 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
| Matthew J. Budoff | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute) | Torrance | United States | 1 |